About the Graves' Orbitopathy Session
Graves' Orbitopathy, or thyroid eye disease, stems from an autoimmune disorder often associated with hyperthyroidism. This condition affects the tissues surrounding the eyes, resulting in symptoms like protruding eyes (proptosis), double vision, dryness, redness, and potentially vision impairment. The immune system erroneously targets the tissues behind the eyes, causing inflammation and swelling. Diagnosis typically involves clinical assessment, imaging (such as CT or MRI scans), and thyroid function tests. Treatment strategies focus on symptom management and may include anti-inflammatory medications, artificial tears for dry eyes, and in severe cases, surgical intervention. A collaborative approach between ophthalmologists and endocrinologists ensures tailored treatment plans to preserve vision and enhance patients' overall well-being.
Topics Covered in Graves' Orbitopathy
Clinical Activity Score
Extraocular Muscle Enlargement
Compressive Optic Neuropathy
TSH Receptor Antibodies
Teprotumumab & IV Steroids
Orbital Decompression
Related Scientific Sessions at IOC 2027
Why Attend the Graves' Orbitopathy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Graves' Orbitopathy work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Graves' Orbitopathy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Graves' Orbitopathy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Graves' Orbitopathy Conference 2027 — FAQs
What is the Graves' Orbitopathy track at IOC 2027?
The Graves' Orbitopathy track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Graves' Orbitopathy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Graves' Orbitopathy sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Graves' Orbitopathy are all welcome — whether presenting or attending.
Can I present my research in the Graves' Orbitopathy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Graves' Orbitopathy sessions?
Yes. IOC 2027 is a hybrid conference — attend the Graves' Orbitopathy track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
